244 related articles for article (PubMed ID: 21875013)
1. [Interstitial lung disease (ILD) in systemic sclerosis (SSc)].
Novak S
Reumatizam; 2010; 57(2):105-8. PubMed ID: 21875013
[TBL] [Abstract][Full Text] [Related]
2. Interstitial lung disease in systemic sclerosis.
Bussone G; Mouthon L
Autoimmun Rev; 2011 Mar; 10(5):248-55. PubMed ID: 20863911
[TBL] [Abstract][Full Text] [Related]
3. Interstitial lung disease associated with systemic sclerosis: what is the evidence for efficacy of cyclophosphamide?
Bérezné A; Valeyre D; Ranque B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Sep; 1110():271-84. PubMed ID: 17911442
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label study.
Bérezné A; Ranque B; Valeyre D; Brauner M; Allanore Y; Launay D; Le Guern V; Kahn JE; Couderc LJ; Constans J; Cohen P; Mahr A; Pagnoux C; Hachulla E; Kahan A; Cabane J; Guillevin L; Mouthon L
J Rheumatol; 2008 Jun; 35(6):1064-72. PubMed ID: 18464307
[TBL] [Abstract][Full Text] [Related]
5. Assessment and management of scleroderma lung disease.
Bolster MB; Silver RM
Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
[TBL] [Abstract][Full Text] [Related]
6. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
[TBL] [Abstract][Full Text] [Related]
7. Desquamative interstitial pneumonia as the initial manifestation of systemic sclerosis.
Swartz JS; Chatterjee S; Parambil JG
J Clin Rheumatol; 2010 Sep; 16(6):284-6. PubMed ID: 20808169
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary function tests.
Behr J; Furst DE
Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v65-7. PubMed ID: 18784151
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic options for systemic sclerosis related interstitial lung diseases.
Mouthon L; Bérezné A; Guillevin L; Valeyre D
Respir Med; 2010 Jul; 104 Suppl 1():S59-69. PubMed ID: 20630349
[TBL] [Abstract][Full Text] [Related]
10. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.
Trad S; Amoura Z; Beigelman C; Haroche J; Costedoat N; Boutin le TH; Cacoub P; Frances C; Wechsler B; Grenier P; Piette JC
Arthritis Rheum; 2006 Jan; 54(1):184-91. PubMed ID: 16385514
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of treatment for systemic sclerosis interstitial lung disease: results from a meta-analysis.
Broad K; Pope JE
Med Sci Monit; 2010 Sep; 16(9):RA187-90. PubMed ID: 20802426
[TBL] [Abstract][Full Text] [Related]
13. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
Kowal-Bielecka O; Kowal K; Highland KB; Silver RM
Semin Arthritis Rheum; 2010 Aug; 40(1):73-88. PubMed ID: 19152959
[TBL] [Abstract][Full Text] [Related]
15. Scleroderma lung: pathogenesis, evaluation, and current therapy.
Co HT; Block JA; Sequeira W
Am J Ther; 2000 Sep; 7(5):321-4. PubMed ID: 11317180
[TBL] [Abstract][Full Text] [Related]
16. [Use of pulmonary function tests and biomarkers studies to diagnose and follow-up interstitial lung disease in systemic sclerosis].
Hua-Huy T; Rivière S; Tiev KP; Dinh-Xuan AT
Rev Pneumol Clin; 2014 Dec; 70(6):335-42. PubMed ID: 25457218
[TBL] [Abstract][Full Text] [Related]
17. Interstitial lung disease as the first manifestation of systemic sclerosis.
van der Kamp R; Tak PP; Jansen HM; Bresser P
Neth J Med; 2007 Nov; 65(10):390-4. PubMed ID: 18057462
[TBL] [Abstract][Full Text] [Related]
18. Interstitial lung disease in systemic sclerosis.
Wells AU; Margaritopoulos GA; Antoniou KM; Denton C
Semin Respir Crit Care Med; 2014 Apr; 35(2):213-21. PubMed ID: 24668536
[TBL] [Abstract][Full Text] [Related]
19. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
20. [Lung involvement in systemic sclerosis].
Posa M; Stelle M; Lador F; Chizzolini C
Rev Med Suisse; 2015 Apr; 11(469):802-6. PubMed ID: 26040160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
